---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-040917"
form_type: "8-K"
ticker: "AVAH"
cik: "0001832332"
company_name: "Aveanna Healthcare Holdings, Inc."
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T19:03:35.286469+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Aveanna Q2 revenue up 6.5% to $472M; raises full-year guidance

## Summary
- Revenue $471.9M (+6.5% YoY); net income $25.6M vs loss $473.9M (absence of $470.2M goodwill impairment).
- Adjusted EBITDA $35.8M (-3.2% YoY, +25.6% seq.); margin 7.6% vs 8.3% prior year.
- Full-year 2023 revenue guidance raised to $1,850M-$1,860M; Adj. EBITDA guidance $132M-$135M.
- PDS segment revenue up $29.6M; HHH segment down $6.0M; Medical Solutions up $5.3M.
- Cash $28M; revolver undrawn with $162M capacity; securitization facility extended to July 2026.

## SEC filing metadata
- accession: 0000950170-23-040917
- form_type: 8-K
- ticker: AVAH
- cik: 0001832332
- company_name: Aveanna Healthcare Holdings, Inc.
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1832332/000095017023040917/0000950170-23-040917-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1832332/000095017023040917/avah-20230810.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-040917
- JSON: https://secwatch.observer/filing/0000950170-23-040917.json
- Plain text: https://secwatch.observer/filing/0000950170-23-040917.txt

## Key facts
- Earnings Releases
  Aveanna Healthcare Holdings, Inc. reported three and six-month periods ended July 1, 2023 results: revenue $471.9 million, net income $25.6 million, EPS $0.13. Guidance raised.
  - Period: three and six-month periods ended July 1, 2023
  - Revenue: $471.9 million
  - Net income: $25.6 million
  - EPS: $0.13
  - Guidance: raised
  - Result: reported results
  source text: Revenue was $471.9 million, a 6.5% increase over the prior year o Gross margin increased 7.0% to $155.3 million, compared to Q2 2022 • Net income was $25.6 million, compared to net loss of $473.9 million in the comparable prior year period o Adjusted EBITDA was $35.8 million, a sequential increase of 25.6% and a 3.2% decrease as compared to the prior year • Full year 2023 revenue guidance raised to a range of $1,850 million to $1,860 million o Full year 2023 Adjusted EBITDA guidance raised to a range of $132 million to $135 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1832332/000095017023040917/0000950170-23-040917-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.